The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1,3-benzothiazol-2-ylamino)-3-oxo-propanoic acid ID: ALA5219686
Chembl Id: CHEMBL5219686
Cas Number: 105397-87-3
PubChem CID: 1615407
Max Phase: Preclinical
Molecular Formula: C10H8N2O3S
Molecular Weight: 236.25
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CC(=O)Nc1nc2ccccc2s1
Standard InChI: InChI=1S/C10H8N2O3S/c13-8(5-9(14)15)12-10-11-6-3-1-2-4-7(6)16-10/h1-4H,5H2,(H,14,15)(H,11,12,13)
Standard InChI Key: ITHJNIIGMKKVJO-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 236.25Molecular Weight (Monoisotopic): 236.0256AlogP: 1.71#Rotatable Bonds: 3Polar Surface Area: 79.29Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.11CX Basic pKa: ┄CX LogP: 1.93CX LogD: -1.26Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.79Np Likeness Score: -2.03
References 1. He R, Wang J, Yu ZH, Moyers JS, Michael MD, Durham TB, Cramer JW, Qian Y, Lin A, Wu L, Noinaj N, Barrett DG, Zhang ZY.. (2022) Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors., 65 (20.0): [PMID:36197449 ] [10.1021/acs.jmedchem.2c01143 ]